CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 666777 | 790793 | 84.3% | |
| CKD 4 | 2008 | 856001 | 1020663 | 83.9% | |
| CKD 5 | 2009 | 165272 | 189325 | 87.3% | |
| CKD 5 | 2010 | 80884 | 88119 | 91.8% | |
| CKD 5 | 2011 | 95622 | 105752 | 90.4% | |
| CKD 5 | 2012 | 104882 | 117209 | 89.5% | |
| CKD 5 | 2013 | 112142 | 125634 | 89.3% | |
| CKD003 | 2014 | 113446 | 124617 | 91.0% | |
| CKD003 | 2015 | 117508 | 128359 | 91.5% | |
| NM84 | 2016 | 94725 | 126631 | 74.8% | |
| NM84 | 2017 | 86743 | 119235 | 72.7% | |
| NM84 | 2018 | 85768 | 120315 | 71.3% | |
| NM84 | 2019 | 63713 | 93409 | 68.2% | |
| NM84 | 2020 | 74852 | 110901 | 67.5% | |
| NM84 | 2022 | 73365 | 107426 | 68.3% | |
| NM84 | 2023 | 52133 | 73598 | 70.8% |
